Hiromichi Ito

16PUBLICATIONS
17CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 17, 2025
Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal comparative study.

Yuki Hirose, Atsushi Oba, Yosuke Inoue

|Apr 10, 2025
Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency.

Koshiro Fukuda, Akiyoshi Kasuga, Yasuyuki Shigematsu

|Apr 09, 2025
Western and Eastern experience in treating perihilar cholangiocarcinoma: retrospective bi-centre study.

Hannes Jansson, Atsushi Oba, Aya Maekawa

|Jun 13, 2024
Schistosoma japonicum-related hepatitis: potential contributor to hepatocellular carcinoma.

S Kato, Y Shigematsu, R Saito

|Jan 12, 2024
A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment.

Kojiro Omiya, Aya Maekawa, Atsushi Oba

|Feb 15, 2023
Role of Intraoperative Assessment of Proximal Bile Duct Margin Status and Additional Resection of Perihilar Cholangiocarcinoma: Can Local Clearance Trump Tumor Biology? A Retrospective Cohort Study.

Fumihiro Kawano, Hiromichi Ito, Atsushi Oba

Pageof 3

Frequent Collaborators

7 joint publications

Atsushi Oba

5 joint publications

Yu Takahashi

2 joint publications

Yasuyuki Shigematsu

1 joint publications

K Inamura